(-)-Oxprenolol is a non-selective beta-adrenergic antagonist, commonly used in the treatment of hypertension and certain cardiac conditions. It is characterized by its ability to block the action of catecholamines like adrenaline on beta-adrenergic receptors, leading to a decrease in heart rate and blood pressure. The compound has a chiral center, which contributes to its specific pharmacological activity, with the (-) enantiomer being the active form. Chemically, it is classified as a phenoxypropanolamine derivative, featuring a phenolic group and a propanolamine structure. Its solubility profile indicates that it is moderately soluble in water, which influences its bioavailability and absorption in the body. The substance is typically administered orally and has a relatively short half-life, necessitating multiple doses throughout the day for sustained therapeutic effects. As with many beta-blockers, (-)-Oxprenolol may have side effects, including fatigue, dizziness, and potential respiratory issues in susceptible individuals. Overall, its pharmacological properties make it a valuable agent in cardiovascular therapy.

(-)-Oxprenolol

22972-96-9: (-)-1-[o-(Allyloxy)phenoxy]-3-isopropylamino-2-propanol, 2-Propanol, 1-[o-(allyloxy)phenoxy]-3-(isopropylamino)-, (-)-, 2-Propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-, (2S)-, (2S)-1-[(1-Methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-2-propanol, 2-Propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-, (S)-

CAS 22972-96-9: (-)-Oxprenolol

(S)-Oxprenolol

Ref: 4Z-O-153

(S)-Oxprenolol

Ref: ST-EA-CP-O127003